Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study
- Creator: Shapiro, Jeremy D. , Thavaneswaran, Subotheni , Tebbutt, Niall C. , Price, Timothy J. , Khasraw, Mustafa , Van Hazel, Guy A. , Waring, Paul M. , Tejpar, Sabine , Simes, John , Gebski, Val J. , Desai, Jayesh , Segelov, Eva , Underhill, Craig R. , Robledo, Kristy P. , Karapetis, Chistos S. , Day, Fiona L. , Nott, Louise M. , Jefford, Michael , Chantrill, Lorraine A. , Pavlakis, Nick
- Resource Type: journal article
- Date: 2018
Controversies in the management of gastrointestinal stromal tumors
- Creator: Yip, Desmond , Zalcberg, John , Ackland, Stephen , Barbour, Andrew P. , Desai, Jayesh , Fox, Stephen , Kotasek, Dusan , Mcarthur, Grant , Smithers, B. Mark
- Resource Type: journal article
- Date: 2014
KRAS mutation testing of metastatic colorectal cancer in Australia: where are we at?
- Creator: Scott, Rodney J. , Fox, Stephen B. , Byron, Keith , Rudzki, Barney , Waring, Paul , Iacopetta, Barry , Desai, Jayesh , Grieu, Fabienne , Amanuel, Benhur , Garrett, Kerryn , Harraway, James , Cheetham, Glenice , Pattle, Neville , Haddad, Afaf
- Resource Type: journal article
- Date: 2014